We provide you with 20 years of free, institutional-grade data for MNK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MNK. Explore the full financial landscape of MNK stock.
| Reported Date | CIK | Ticker | Type |
|---|
Mallinckrodt plc(NYSE MKT:MNK) 
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Ami...
Website: http://www.mallinckrodt.com
Founded: 1867
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
The information provided in this report about MNK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.